| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.06▼ | 1.05▼ | 1.06▼ | 1.11▼ | 1.14▼ |
| MA10 | 1.05▼ | 1.06▼ | 1.07▼ | 1.13▼ | 1.18▼ |
| MA20 | 1.06▼ | 1.07▼ | 1.09▼ | 1.16▼ | 1.33▼ |
| MA50 | 1.07▼ | 1.11▼ | 1.13▼ | 1.22▼ | 1.38▼ |
| MA100 | 1.10▼ | 1.14▼ | 1.16▼ | 1.37▼ | 1.48▼ |
| MA200 | 1.12▼ | 1.16▼ | 1.20▼ | 1.41▼ | 1.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▲ | -0.002▼ | -0.006▼ | -0.031▼ |
| RSI | 37.286▼ | 32.687▼ | 28.720▼ | 37.687▼ | 36.385▼ |
| STOCH | 47.500 | 36.667 | 22.083 | 22.998 | 11.520▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -144.601▼ | -138.684▼ | -130.484▼ | -223.071▼ | -92.201 |
|
Tuesday, January 20, 2026 04:02 AM
SHELTON, CT / / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus ...
|
|
Tuesday, January 13, 2026 09:35 AM
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
|
|
Sunday, November 30, 2025 04:00 PM
SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 1.055 | 1.07 | 1.04 | 1.04 | 327,198 |
| 27/01/26 | 1.12 | 1.13 | 1.05 | 1.08 | 352,468 |
| 26/01/26 | 1.14 | 1.1635 | 1.11 | 1.11 | 358,409 |
| 23/01/26 | 1.15 | 1.16 | 1.13 | 1.15 | 259,545 |
| 22/01/26 | 1.19 | 1.19 | 1.14 | 1.15 | 195,854 |
| 21/01/26 | 1.16 | 1.21 | 1.16 | 1.18 | 260,910 |
| 20/01/26 | 1.17 | 1.18 | 1.13 | 1.13 | 221,216 |
| 16/01/26 | 1.15 | 1.20 | 1.14 | 1.18 | 251,327 |
| 15/01/26 | 1.17 | 1.17 | 1.13 | 1.13 | 173,339 |
| 14/01/26 | 1.20 | 1.2168 | 1.14 | 1.15 | 213,380 |
|
|
||||
|
|
||||
|
|